You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
泰恩康(301263.SZ):和胃整腸丸在西南和北方區域還存在很大的市場空間 爭取打造為超10億元的腸胃領域知名產品
格隆匯 06-19 16:10

格隆匯6月19日丨泰恩康(301263.SZ)6月16日接受特定對象調研時表示,經過20多年的推廣,和胃整腸丸已經成為腸胃領域的知名產品,安全性和療效顯著,在廣東、廣西等沿海地區已成為家庭常備用藥。和胃整腸丸從2020年開始受到疫情的影響,泰國廠家的生產能力受到比較大的影響,2021年還受到海運運力緊張的影響,導致市場處於缺貨的狀態,目前在滿足現有渠道的缺貨補庫存需求後,公司會進行全國性的推廣。從銷售區域來看,在西南和北方區域還存在很大的市場空間,隨着公司加大推廣力度,以及加深與和胃整腸丸授權廠商的合作,將進一步擴大該品種的市場佔有率,爭取打造為超10億元的腸胃領域知名產品。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account